EDITORIAL
Published on 13 Jun 2024
Editorial: Endogenous danger signals in cancer immunology and immunotherapy
doi 10.3389/fimmu.2024.1438972
- 593 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Endogenous Danger Signals in Cancer Immunology and Immunotherapy
Endogenous Danger Signals in Cancer Immunology and Immunotherapy
8,477
Total downloads
23k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
BRIEF RESEARCH REPORT
Published on 13 May 2024
Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration
doi 10.3389/fimmu.2024.1358800
- 1,639 views
- 1 citation
ORIGINAL RESEARCH
Published on 13 Mar 2024
LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells
doi 10.3389/fimmu.2024.1332922
- 1,893 views
- 2 citations
REVIEW
Published on 13 Mar 2023
The unfolding story of dying tumor cells during cancer treatment
doi 10.3389/fimmu.2023.1073561
- 4,452 views
- 5 citations
REVIEW
Published on 06 Oct 2022
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases
doi 10.3389/fimmu.2022.1008047
- 2,468 views
- 2 citations
REVIEW
Published on 12 May 2022
The Controversial Role of IL-33 in Lung Cancer
doi 10.3389/fimmu.2022.897356
- 3,930 views
- 9 citations
ORIGINAL RESEARCH
Published on 21 Jun 2021
High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells
doi 10.3389/fimmu.2021.675731
- 3,481 views
- 17 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Mucosal Immunity
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 23kTopic views
- 14kArticle views
- 8,477Article downloads